Clinical Trial Update: PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of tocilizumab with GVHD prophylaxis to prevent acute and chronic GVHD after allogeneic stem cell transplant; trial completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Hematologic Malignancy | Phase 2 | Status: COMPLETED | Results posted: 2023-04-19